We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tricky....
Thanks for that, puts a bit of meat on the bone, been in over a year now so a bit longer won't make any difference!!
Regards lj
£1.30-1.60 is a reasonable target with what we know.
What we don't know off is where the unexpected revenue / sp will come from. If lockdown is reinstated with the new Brazilian variant taking control, testing and covid related companies such as ODX will once again be the spotlight. FYI, I'd rather the world come back to normality than make a few quid off devastating events, but if the opportunity arises I'll take it.
All imo, gl all
Lovejoy, not really guesswork. Just a process of deduction based on existing regulations. It should be within 20 or 30 days (working days is usually meant) from the date of the contract being agreed- 11th February. So it could be from any time from now up until the 25th March. If there has been no challenge- and we haven't heard of any- it could be anytime until 11th March. The government have just lost a judicial review for not publishing contracts as required so they will be under pressure not to repeat that since the matter has been clarified now they can't claim ignorance. However, if they had an excuse- such as wanting to wait for results of the evaluations from several firms who may be able to deliver both high standards and more accessible, faster tests than I really wouldn't be surprised if they wait until those results came in and defend their decision if necessary. No-one would go to prison for it if they didn't meet the deadline. They would use the defence of acting reasonably in the light of the circumstances. I think it's equally likely that they allowed ODX to put the RNS out, knowing that results are expected in good time to satisfy regulations. The tests will be delivered by April so not long to wait now.
I would pay no attention to this board in making a decision to invest I don't care if you do or don't it doesn't benefit me I'm not a day trader so I'm not selling on highs and deramping to buy on lows.
I admit at times I've tried playing that game but I'm just an average person trying to change my life for the better and realise only real parasites play that game.
I would suggest you look at facts and only facts wether you choose to listen to people is up to you but tthis board has some lovely people but a hell of a lot of day traders.
I'd just stay off here and look at share price on Google but anyone not getting in soon will of missed the boat and I'm all aboard so buy or sell I'm waiting until at least £1.30-£1.60 and make my mind up then good luck newbies only share I'm in now
They have the order they were waiting on Goverment confirming test to be mass produced in the mean time they have been mass producing covid19 antigen test for other business pipelines and are expected to reach the 2.millionnper week capacity by mid March Only a guess of course
Does anyone actually now a date when odx can confirm the order or is it all guesswork??
Regards lj
Yes ODX have done an awful job 10 bagging their SP and transforming their facilities and partnerships in a single year.
Awful I tell you
ODX ,don’t do facts or figures ,they believe in fables ! The “gold standard “ test , ramped up production for “ what” RNS,s over the last year designed to halt any Sp movement ,with target dates never fulfil or adequate explanations why not, they haven’t put any orders numbers, costs or contract details up , except for 3 year deal with surescreen ,,,, but again weres the figures ,the board is totally arrogant and disgraceful in they management of the vast majority of they share holders ,an utter shameful communication trait of lack lustre information,God I hope there products are better then there management style .
@Brighty1: you seem to have missed an important section of the NCYT RNS titled "New UK DHSC Contract"
"Under the terms of the contract, which is in two phases, Primerdesign will supply its products to the DHSC for up to six months. Phase one has an initial fixed term of 14 weeks with the potential to extend supply by a further 10 weeks. This first phase of the contract will involve the immediate deployment of 300 PCR instruments, related kits and support services with a minimum value of £150 million for the first 14 weeks. Based on this initial period, a further £100 million of revenue could be expected for the subsequent 10 weeks, however volumes can be varied up or down subject to certain notice criteria given by the DHSC."
Facts, Figures and timescales clearly set out for their investors
2m tests a week from April (possibly sooner, currently c.1m.)
Expecting 200/250k RTC Covid tests per week - expected at £1.60 per test to ODX / 80p per test profit.
Remaining 1.8m tests will be split Antigen/Antibody - expected at £5 per test / £2.50 profit per test.
Holding ODX is not really worrying me at all, you can see what's around the corner, despite not being fully in the public domain. oh.
The Littleport business is worth 60p a share on its own, so at the moment you have the covid business for around 30p a share when it could be worth £2.00-5.00. I would say the upside is more likely than downside. DYOR and work out what's coming.
Just a heads up for those expecting an RNS with hard and fast revenue numbers attached to a Government contract win. It is worth noting that when NCYT announced its contract win with the UK Department of Health and Social Care (pasted below for clarity) it didn't include revenue, just details of the order volume in units (288,000 tests per week). i.e. We might not get financial numbers in a forthcoming DHSC contract RNS but we should get an idea of units contracted. e.g. we know 2 million a week is the optimum, according to the ODX 11th February RNS announcing the UK Government contract.
I was invested in NCYT at the time - and I still am - and would add that a further DHSC contract was awarded to NCYT and announced via RNS in September, this time including revenue. Both RNS' were received very well by the market and, as we know, resulted in significant share price rises.
I am anticipating a contract to be RNS'd by ODX perhaps without financial numbers but with a unit ratification of how many per week / per month and for ODX to then confirm the financial value at a later date via a trading update / interims / full year results etc. If this happened it would be in keeping with the DHSC NCYT initial announcement last April. Obviously, if ODX can confirm actual financial numbers all the better.
Exciting times for ODX and its share holders. Good luck, Brighty
"Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it has signed a supply contract with the UK Department of Health and Social Care (DHSC) for its COVID-19 (CE IVD) polymerase chain reaction (PCR) test, developed by Primerdesign, the Company's molecular diagnostics division based in the UK.
Under the terms of the agreement, Novacyt will supply its COVID-19 test to the DHSC for an initial term of six months, starting from 4 May 2020. Novacyt has initially committed to supply 288,000 tests per week to the DHSC for use in the NHS, with the option to expand the agreement".